http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106497991-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-88 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 |
filingDate | 2016-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106497991-B |
titleOfInvention | One kind synthesizing caffeinic method by substrate of levodopa |
abstract | The invention discloses one kind to synthesize caffeinic method by substrate of levodopa, belongs to biological chemical field.The present invention is using levodopa as substrate biosynthesis caffeic acid.With it is previous using l-tyrosine compared with the method for transformation of substrate, this method substrate solubility is higher, and yield is high, conversion ratio, and high production efficiency.Compared with chemical synthesis process, the product of this method is single trans- caffeic acid, does not need further to separate isomer.Caffeinic yield is up to 910.90mg/L, conversion ratio 99.70% after reaction 6 hours. |
priorityDate | 2016-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 361.